Banco Patagonia S.A. (BCBA:BPAT)

Ligand Pharmaceuticals Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	324,171	351,996	353,987	94,214	39,654	32,979
Investment Securities	2,466,502	2,368,337	912,232	1,478,419	371,312	145,442
Trading Asset Securities	45,614	85,179	162,900	45,985	14,525	6,034
Total Investments	2,512,117	2,453,516	1,075,132	1,524,404	385,837	151,475
Gross Loans	2,431,980	2,278,886	1,413,634	815,670	325,007	172,115
Allowance for Loan Losses	-27,943	-20,110	-11,941	-11,437	-6,340	-6,762
Net Loans	2,404,038	2,258,776	1,401,692	804,233	318,668	165,352
Property, Plant & Equipment	167,114	155,575	217,205	105,257	34,992	17,647
Other Intangible Assets	4,525	4,728	6,361	-	-	-
Investments in Real Estate	721.34	671.04	877.8	283.37	107.21	69.55
Accrued Interest Receivable	35,180	29,175	34,623	12,459	7,027	5,119
Other Receivables	222,645	104,555	61,824	27,901	2,696	1,813
Restricted Cash	501,636	491,261	508,155	220,541	94,219	58,302
Other Current Assets	214,218	107,328	2,228,855	32,085	12,336	5,972
Long-Term Deferred Tax Assets	339.97	1,030	7,083	458.26	1,007	4,569
Other Long-Term Assets	38,529	41,991	71,459	31,642	8,611	8,617
Total Assets	6,425,235	6,000,602	5,967,253	2,855,998	906,429	452,648
Accounts Payable	-	5,017	6,705	2,541	-	1,389
Accrued Expenses	39,187	246,196	201,588	94,281	28,470	12,828
Interest Bearing Deposits	4,052,856	4,060,772	3,895,736	1,850,480	589,316	287,624
Non-Interest Bearing Deposits	287,252	-	-	162,732	65,577	37,787
Total Deposits	4,340,109	4,060,772	3,895,736	2,013,212	654,893	325,411
Short-Term Borrowings	37,863	10,834	979.77	3,492	1,532	1,466
Current Portion of Leases	-	5,289	2,794	2,153	871.81	471.14
Current Income Taxes Payable	4,552	3,379	140,922	7,980	400.28	2,081
Accrued Interest Payable	55,208	70,538	117,311	48,768	8,190	2,421
Other Current Liabilities	267,942	143,781	226,249	82,003	45,781	20,158
Long-Term Debt	46,252	39,465	110,988	61,407	14,547	6,183
Long-Term Leases	-	5,190	2,800	2,494	1,002	674.35
Long-Term Unearned Revenue	14,050	15,787	23,822	15,138	3,730	1,841
Pension & Post-Retirement Benefits	-	1,824	1,048	990.6	275.26	247.33
Long-Term Deferred Tax Liabilities	77,312	76,606	2,173	18,277	-	-
Other Long-Term Liabilities	138,325	4,714	4,690	2,782	1,296	2,056
Total Liabilities	5,020,800	4,689,393	4,737,805	2,355,520	760,990	377,227
Common Stock	719.15	719.15	719.15	719.15	719.15	719.15
Additional Paid-In Capital	217.19	217.19	217.19	217.19	217.19	217.19
Retained Earnings	996,541	890,892	775,410	314,572	82,176	42,602
Comprehensive Income & Other	406,958	419,380	453,102	184,969	62,327	31,884
Total Common Equity	1,404,434	1,311,208	1,229,448	500,477	145,440	75,422
Minority Interest	0.01	0.01	0.01	0	-	-
Shareholders' Equity	1,404,434	1,311,208	1,229,448	500,477	145,440	75,422
Total Liabilities & Equity	6,425,235	6,000,602	5,967,253	2,855,998	906,429	452,648
Total Debt	84,115	60,778	117,561	69,547	17,952	8,795
Net Cash (Debt)	285,671	376,397	399,325	497,492	161,099	42,185
Net Cash Growth	-75.77%	-5.74%	-19.73%	208.81%	281.89%	-
Net Cash Per Share	397.24	523.39	555.28	691.78	224.01	58.66
Filing Date Shares Outstanding	719.15	719.15	719.15	719.15	719.15	719.15
Total Common Shares Outstanding	719.15	719.15	719.15	719.15	719.15	719.15
Book Value Per Share	1952.92	1823.29	1709.60	695.93	202.24	104.88
Tangible Book Value	1,399,910	1,306,481	1,223,087	500,477	145,440	75,422
Tangible Book Value Per Share	1946.63	1816.71	1700.75	695.93	202.24	104.88

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.